The second Life Sciences Sector Deal, with industry investment from 10 companies and £79 million from governement, will support healthcare innovation and back businesses to create high-paid, high-quality jobs. Tens of thousands of lives could be saved by pioneering research to detect deadly diseases before symptoms even appear, thanks to new collaborations.
The challenge will build a study of 100,000 healthy people in its first four years to develop new diagnostic tests using artificial intelligence (AI) and machine learning. The programme will then grow to include more than 1 million people through further funding arrangements and will be the first of its kind in a national health programme.
The deal signals a vote of confidence in UK industry, with global biopharmaceutical company UCB investing around £1 billion in research and development, including in a new state-of-the-art facility.